Antioxidant properties of the cerebrospinal fluid in neurodegenerative diseases

被引:0
|
作者
Kolmakova, T. S. [1 ]
Smirnova, O. B. [1 ]
Belyakova, E. I. [1 ]
机构
[1] S Fed Univ, Pedag Inst, Rostov Na Donu, Russia
关键词
catalase; SOD; free radical oxidation; antioxidant system; cerebrospinal fluid; brain; experimental allergic encephalomyelitis;
D O I
10.1134/S1819712410010083
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cerebrospinal fluid contains elements of the antioxidant system that are involved in the maintenance of homeostasis of the nervous tissue and its protection from free radical damage. Functional imbalances between antioxidant enzymes of the cerebrospinal fluid, such as superoxide dismutase (SOD) and catalase, have been revealed in schizophrenia, epilepsy, and multiple sclerosis. In neurological diseases SOD activity was higher, while catalase activity was lower as compared to the group of patients suffering from osteochondrosis, which was used for comparison. A decrease in the antioxidant capacity of the cerebrospinal fluid is associated with the accumulation of substances that induce oxidative stress in the brain. Incubation of patients' cerebrospinal fluid with homogenates of rat brain structures resulted in the activation of free radical processes. In canines, the development of experimental allergic encephalomyelitis (EAE) was accompanied by a decrease in the activity of enzymes of antioxidant (AO) defense as compared to intact animals. In animals that did not become ill the enzymatic activity was similar to the control. We hypothesized that the antioxidant system of the cerebrospinal fluid regulates the oxidative homeostasis of the brain. Inhibition of this system is one of the causes of oxidative stress in degenerative diseases of the nervous system.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 50 条
  • [31] Transforming growth factor-β1 in the cerebrospinal fluid of patients with distinct neurodegenerative diseases
    Masuda, Tomoyuki
    Itoh, Junko
    Koide, Takuya
    Tomidokoro, Yasushi
    Takei, Yosuke
    Ishii, Kazuhiro
    Tamaoka, Akira
    JOURNAL OF CLINICAL NEUROSCIENCE, 2017, 35 : 47 - 49
  • [32] Mendelian randomization study of causal link from Cerebrospinal fluid metabolomics to neurodegenerative diseases
    Zhang, Jingjing
    Zhang, Xin
    Xiao, Boan
    Ouyang, Jiecai
    Wang, Peng
    Peng, Xiaobin
    NEUROGENETICS, 2024, 26 (01)
  • [33] Effects of age and glucose levels on lactate levels in cerebrospinal fluid examination of neurodegenerative diseases
    Nakano, Fumihito
    Sakushima, Ken
    Umeki, Reona
    Yabe, Ichiro
    Endoh, Akira
    Sasaki, Hidenao
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 378 : 45 - 48
  • [34] Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
    Arai, H
    Morikawa, Y
    Higuchi, M
    Matsui, T
    Clark, CM
    Miura, M
    Machida, N
    Lee, VMY
    Trojanowski, JQ
    Sasaki, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 262 - 264
  • [35] 8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative Diseases
    Gmitterova, K.
    Heinemann, U.
    Gawinecka, J.
    Varges, D.
    Ciesielczyk, B.
    Valkovic, P.
    Benetin, J.
    Zerr, I.
    NEURODEGENERATIVE DISEASES, 2009, 6 (5-6) : 263 - 269
  • [36] Transforming growth factor-β1 levels in the cerebrospinal fluid of patients with neurodegenerative diseases
    Ishii, K.
    Masuda, T.
    Itoh, J.
    Koide, T.
    Tomidokoro, Y.
    Takei, Y.
    Tamaoka, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 306 - 306
  • [37] Cerebrospinal fluid levels of F2-isoprostanes in patients with neurodegenerative diseases.
    Morrow, JD
    Roberts, LJ
    Montine, TJ
    Beal, MF
    Cudkowicz, ME
    O'Donnell, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 165 - 165
  • [38] 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases
    Zerr, I.
    Gawinecka, J.
    Gmitterowa, K.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S96 - S96
  • [39] Serum and cerebrospinal fluid phosphorylated neurofilament heavy protein concentrations in equine neurodegenerative diseases
    Edwards, Lisa A.
    Donnelly, Callum G.
    Reed, Stephen M.
    Valberg, Stephanie
    Chigerwe, Munashe
    Johnson, Amy L.
    Finno, Carrie J.
    EQUINE VETERINARY JOURNAL, 2022, 54 (02) : 290 - 298
  • [40] The presence of biological markers of neurodegeneration in the cerebrospinal fluid of patients suffering from neurodegenerative diseases
    Vranova, H.
    Mares, J.
    Nevrly, M.
    Stejskal, D.
    Herzig, R.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 213 - 213